Abstract:The multidrug resistance (MDR) 1 gene encodes a 170-kDa membrane transporter called P-glycoprotein, which plays an important role in protecting cells against lipophilic xenobiotics by the way of an ATP-dependent cellular efflux mechanism. Three polymorphisms of MDR1, 3435C > T located in exon 26, 1236C > T in exon 12 and 2677G > T/A in exon 21 were the most extensively studied and were identified functionally important and ethnically diverse mapping to the gene region. Considering the potential influence of altering MDR1 activity, it is plausible that MDR1 polymorphisms might play a role in the development of cancer. Although the effects of MDR1 polymorphisms on susceptibility to human cancer have been investigated in many studies, the results still remain conflicting.To resolve these conflicts, we performed a quantitative synthesis of the association between these three polymorphisms and cancer risk, including 52 studies (15789 cases and 20274 controls) for 3435C > T polymorphism, 10 studies (2101 cases and 2842 controls) for 1236C > T polymorphism and 18 studies (3585 cases and 4351 controls) for 2677G > T/A polymorphism.The stratified analyses for 3435C > T polymorphism, individuals with T-allele in 3435C > T had significantly higher ALL risks (TT versus CC: OR =1.286, 95% CI =1.123-1.474); significantly elevated risks were observed among Caucasian populations (TT versus CC: OR =1.276, 95% CI =1.112-1.464). When restricting the analysis to the source of controls, we found that HB (hospital-based) genetic models had higher risks (TT versus CC: OR =1.307, 95% CI =1.046-1.632), as well as in PB (population-based) genetic models (TT versus CC: OR =1.294, 95% CI =1.079-1.55).The T/A-allele frequency of 2677G > T/A polymorphism was associated with higher risk of cancer (TT + TA + AA vs. GG: OR =1.348, 95% CI =1.031-1.762), significantly elevated risks were observed among Asian populations (TT + TA + AA vs. GG: OR =1.642, 95% CI =1.340-2.012), and elevated risks could be associated with PB models (TT + TA + AA vs. GG: OR =1.641, 95% CI =1.018-2.646).Our meta-analysis suggested that 3435C > T polymorphism and 2677G > T/A polymorphism were associated with cancer risk when all studies were pooled together, while 1236C > T polymorphism not.

Association between single nucleotide polymorphism of 309 T/G in murine doubleminute 2 gene and the susceptibility of non-small cell lung cancer: a Meta-analysis

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

SNP rs17079281 Decreases Lung Cancer Risk Through Creating an YY1-Binding Site to Suppress DCBLD1 Expression

A Genetic Variant In Mir-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis Of 15 Case-Control Studies

The Mdm2 T309g Polymorphism And Risk Of Lung Cancer: An Updated Meta-Analysis Of 10,186 Cases And 14,155 Controls

Association of MDM2 Promoter T309G Polymorphism with Oral Cancer Risk: A Meta-Analysis of 3,536 Subjects

MDM2 SNP309T>G Polymorphism with Hepatocellular Carcinoma Risk: A Meta-analysis

Association Between MDM2 Rs 2279744 Polymorphism and Breast Cancer Susceptibility: a Meta-Analysis Based on 9,788 Cases and 11,195 Controls.

A Genetic Polymorphism In Pre-Mir-27a Confers Clinical Outcome Of Non-Small Cell Lung Cancer In A Chinese Population

Study On Association Between Single Nucleotide Polymorphisms In Murine Double Minute 2 And Susceptibility Of Hepatocellular Carcinoma

Mdm2 Promoter Snp309 Is Associated With Risk Of Occurrence And Advanced Lymph Node Metastasis Of Nasopharyngeal Carcinoma In Chinese Population

MDM2 309 T/G polymorphism is associated with lung cancer risk among Asians.

MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis

Association Between Mitogen-Activated Protein Kinase Kinase Kinase 1 Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis of 20 Case-Control Studies

Association between single nucleotide polymorphisms in MDM2 and the susceptibility of hepatocellular carcinoma(HCC)

Meta-analysis of MDM2 SNP309 polymorphism and susceptibility to oral cancer

MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis

Murine Double Minute 2 Promoter Snp309 Polymorphism And Prostate Cancer Risk: A Meta-Analysis

The Association Between Polymorphisms in the MDR1 Gene and Risk of Cancer: a Systematic Review and Pooled Analysis of 52 Case–control Studies

Polymorphisms in the MDM2 Gene and Risk of Malignant Bone Tumors: a Meta-Analysis

A PRISMA-compliant Meta-Analysis of MDM4 Genetic Variants and Cancer Susceptibility.